Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel and Emerging Therapies for Inflammatory Bowel Disease
Badr Al‐Bawardy, Raina Shivashankar, Deborah D. Proctor
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 214
The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer
Gang Guo, Zhaobang Tan, Yaping Liu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
IBD disease-modifying therapies: insights from emerging therapeutics
Niranjan G. Kotla, Yury Rochev
Trends in Molecular Medicine (2023) Vol. 29, Iss. 3, pp. 241-253
Closed Access | Times Cited: 64
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases
Claudia Herrera‐deGuise, X Serra-Ruiz, Ernesto Lastiri, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 47
Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines
Jisu Kim, Shuya Zhang, Ying Zhu, et al.
Journal of Ginseng Research (2023) Vol. 47, Iss. 5, pp. 627-637
Open Access | Times Cited: 42
Nanotechnology-enabled M2 macrophage polarization and ferroptosis inhibition for targeted inflammatory bowel disease treatment
Yuge Zhao, Weimin Yin, Zichen Yang, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 339-353
Closed Access | Times Cited: 16
Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011
Dinesh Thapa, Mohan Patil, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 148-148
Open Access | Times Cited: 2
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
Kathy Weisel, Nicola Scott, Scott B. Berger, et al.
BMJ Open Gastroenterology (2021) Vol. 8, Iss. 1, pp. e000680-e000680
Open Access | Times Cited: 59
Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation
Muhammad Ali Muzammil, Fnu Fariha, Tirath Patel, et al.
Cureus (2023)
Open Access | Times Cited: 28
Modulating the Microbiome for Crohn’s Disease Treatment
Rachael Gowen, Ahmed Gamal, Luca Di Martino, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 828-840
Open Access | Times Cited: 26
Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis
V. Michael Holers, Kristen Demoruelle, Jane H. Buckner, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 601-613
Closed Access | Times Cited: 13
Probiotics for inflammatory bowel disease: Is there sufficient evidence?
Yueying Ma, Dandan Yang, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Roseburia intestinalis‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses
Hwa Seung Han, Soonjae Hwang, Seung Young Choi, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 8
Electroacupuncture at ST36 Relieves Visceral Hypersensitivity Based on the Vagus-Adrenal Axis in the Remission Stage of Ulcerative Colitis
Mingwei Fan, Tan Chen, Jinlan Tian, et al.
Neuromodulation Technology at the Neural Interface (2025)
Closed Access | Times Cited: 1
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Haokun Shen, Zitong Zhao, Zengjue Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 594-594
Open Access | Times Cited: 33
Exopolysaccharide from Lactobacillus rhamnosusZFM231 alleviates DSS‐induced colitis in mice by regulating gut microbiota
Cheng Wan, Wenwen Qian, Wei Liu, et al.
Journal of the Science of Food and Agriculture (2022) Vol. 102, Iss. 15, pp. 7087-7097
Closed Access | Times Cited: 31
The Role of Seaweed Polysaccharides in Gastrointestinal Health: Protective Effect against Inflammatory Bowel Disease
N. M. Liyanage, D. P. Nagahawatta, Thilina U. Jayawardena, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1026-1026
Open Access | Times Cited: 22
Recent Advances in Cell‐Based In Vitro Models to Recreate Human Intestinal Inflammation
Maria Helena Macedo, Mafalda D. Neto, Lorenzo Pastrana, et al.
Advanced Science (2023) Vol. 10, Iss. 31
Open Access | Times Cited: 20
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
Marcello Imbrizi, Fernando Magro, Cláudio Saddy Rodrigues Coy
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1272-1272
Open Access | Times Cited: 18
From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems
Jiaojiao Yang, Dingwei Li, Mengjiao Zhang, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 568-591
Closed Access | Times Cited: 17
Review of the Potential of Probiotics in Disease Treatment: Mechanisms, Engineering, and Applications
Mingkang Liu, Jinjin Chen, Ida Putu Wiweka Dharmasiddhi, et al.
Processes (2024) Vol. 12, Iss. 2, pp. 316-316
Open Access | Times Cited: 8
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis
Laurent Peyrin‐Biroulet, Peter Bossuyt, Dominik Bettenworth, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1808-1825
Open Access | Times Cited: 7
Mechanism‐driven strategies for prevention of rheumatoid arthritis
V. Michael Holers, Kristine A. Kuhn, M. Kristen Demoruelle, et al.
Rheumatology & autoimmunity (2022) Vol. 2, Iss. 3, pp. 109-119
Open Access | Times Cited: 27
Polysaccharides from Garlic Protect against Liver Injury in DSS-Induced Inflammatory Bowel Disease of Mice via Suppressing Pyroptosis and Oxidative Damage
Xinyi Zhan, Weijie Peng, Zhuqiang Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 27
Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases
Duncan Rutherford, Gwo‐Tzer Ho
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 9, pp. 1488-1498
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top